Lumina Specialist Hospital Business Plan › Section 16 › Conclusion

Lumina Specialist Hospital addresses a real and measurable gap:
advanced specialist care for an under-served, growing province, funded
by a well-capitalised but geographically uneven private health
system.

The investment case rests on durable fundamentals — acute specialist
scarcity, a rising chronic-disease burden, an ageing insured pool and a
diversified, partly annuity revenue base. On conservative re-derivation,
the Project clears its cost of capital, with a base-case project IRR of
16.8% and an equity IRR of 17.2% to a Year-7 exit.

The case is not without real risks, and this Plan has flagged them
candidly: a thin break-even margin of safety, sub-1.0x debt-service
cover through the ramp, high initial leverage, concentrated payer power,
an imported-equipment FX exposure, and equity returns that depend
materially on the exit multiple and timing — all against the long-run
backdrop of NHI. None is disqualifying, but each warrants careful
structuring and independent due diligence.

Appropriately structured — with a conservative ramp, a properly sized
reserve, a step-up covenant package, early scheme contracting and a
strong management team — Lumina offers lenders financeable, well-secured
exposure and offers equity investors and development-finance partners an
opportunity to combine competitive returns with tangible
healthcare-access and transformation impact. The Sponsor welcomes
engagement, due diligence and discussion of terms.

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Lumina Health Holdings (Pty) Ltd.